1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen WQ, Zheng RS, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Greten TF, Wang XW and Korangy F: Current
concepts of immune based treatments for patients with HCC: From
basic science to novel treatment approaches. Gut. 64:842–848. 2015.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
Surg Oncol. 15:962–971. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ye QH, Qin LX, Forgues M, He P, Kim JW,
Peng AC, Simon R, Li Y, Robles AI, Chen Y, et al: Predicting
hepatitis B virus-positive metastatic hepatocellular carcinomas
using gene expression profiling and supervised machine learning.
Nat Med. 9:416–423. 2003. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Iizuka N, Oka M, Yamada-Okabe H, Nishida
M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Budhu A, Forgues M, Ye QH, Jia HL, He P,
Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY and Wang XW:
Prediction of venous metastases, recurrence, and prognosis in
hepatocellular carcinoma based on a unique immune response
signature of the liver microenvironment. Cancer Cell. 10:99–111.
2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fan W and Ye G: Microarray analysis for
the identification of specific proteins and functional modules
involved in the process of hepatocellular carcinoma originating
from cirrhotic liver. Mol Med Rep. 17:5619–5626. 2018.PubMed/NCBI
|
15
|
Gulubova MV: Expression of cell adhesion
molecules, their ligands and tumour necrosis factor alpha in the
liver of patients with metastatic gastrointestinal carcinomas.
Histochem J. 34:67–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ploverini P: Cellular adhesion molecules;
newly identified mediators of angiogenesis. Am J Pathol.
148:1023–1029. 1996.PubMed/NCBI
|
17
|
McGrogan D and Bookstein R: Tumor
suppressor genes in prostate cancer. Semin Cancer Biol. 8:11–19.
1997. View Article : Google Scholar : PubMed/NCBI
|
18
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
19
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
20
|
Akiyama SK, Larjava H and Yamada KM:
Differences in the biosynthesis and localization of the fibronectin
receptor in normal and transformed cultured human cells. Cancer
Res. 50:1601–1607. 1990.PubMed/NCBI
|
21
|
Koop S, Schmidt EE, MacDonald IC, Morris
VL, Khokha R, Grattan M, Leone J, Chambers AF and Groom AC:
Independence of metastatic ability and extravasation: Metastatic
ras-transformed and control fibroblasts extravasate equally well.
Proc Natl Acad Sci USA. 93:11080–11084. 1996. View Article : Google Scholar : PubMed/NCBI
|
22
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
O'Donnell JP, Marsh HM, Sondermann H and
Sevier CS: Disrupted hydrogen-bond network and impaired ATPase
activity in an Hsc70 cysteine mutant. Biochemistry. 57:1073–1086.
2018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Mayer MP and Bukau B: Hsp70 chaperones:
Cellular functions and molecular mechanism. Cell Mol Life Sci.
62:670–684. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xie W, Zhang L, Jiao H, Guan L, Zha J, Li
X, Wu M, Wang Z, Han J and You H: Chaperone-mediated autophagy
prevents apoptosis by degrading BBC3/PUMA. Autophagy. 11:1623–1635.
2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Majeski AE and Dice JF: Mechanisms of
chaperone-mediated autophagy. Int J Biochem Cell Biol.
36:2435–2444. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang X, Wang Q, Lin H, Li S, Sun L and
Yang Y: HSP72 and gp96 in gastroenterological cancers. Clin Chim
Acta. 417:73–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Brognard J and Newton AC: PHLiPPing the
switch on Akt and protein kinase C signaling. Trends Endocrinol
Metab. 19:223–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Qiao M, Iglehart JD and Pardee AB:
Metastatic potential of 21T human breast cancer cells depends on
Akt/protein kinase B activation. Cancer Res. 67:5293–5299. 2007.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Hattori M, Fujiyama A, Taylor TD, Watanabe
H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK, et al:
The DNA sequence of human chromosome 21. Nature. 405:311–319. 2000.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Banerjee D and Nandagopal K: Potential
interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF
transcription factor in down syndrome-related Alzheimer disease.
Cell Mol Neurobiol. 27:1117–1126. 2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ng BG, Wolfe LA, Ichikawa M, Markello T,
He M, Tifft CJ, Gahl WA and Freeze HH: Biallelic mutations in CAD,
impair de novo pyrimidine biosynthesis and decrease glycosylation
precursors. Hum Mol Genet. 24:3050–3057. 2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Gunning PW, Ghoshdastider U, Whitaker S,
Popp D and Robinson RC: The evolution of compositionally and
functionally distinct actin filaments. J Cell Sci. 128:2009–2019.
2015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Guo C, Liu S, Wang J, Sun MZ and Greenaway
FT: ACTB in cancer. Clin Chim Acta. 417:39–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Cappell SD, Chung M, Jaimovich A, Spencer
SL and Meyer T: Irreversible APC (Cdh1) inactivation underlies the
point of no return for cell-cycle entry. Cell. 166:167–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Beavon IR: The E-cadherin-catenin complex
in tumour metastasis: Structure, function and regulation. Eur J
Cancer. 36:1607–1620. 2000. View Article : Google Scholar : PubMed/NCBI
|
38
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Alloatti G, Montrucchio G, Lembo G and
Hirsch E: Phosphoinositide 3-kinase gamma: Kinase-dependent and
-independent activities in cardiovascular function and disease.
Biochem Soc Trans. 32:383–386. 2004. View Article : Google Scholar : PubMed/NCBI
|
40
|
Rubio I, Wittig U, Meyer C, Heinze R,
Kadereit D, Waldmann H, Downward J and Wetzker R: Farnesylation of
Ras is important for the interaction with phosphoinositide 3-kinase
gamma. Eur J Biochem. 266:70–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
41
|
Uehara M, McGrath MM, Ohori S, Solhjou Z,
Banouni N, Routray S, Evans C, DiNitto JP, Elkhal A, Turka LA, et
al: Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ. Nat
Commun. 8:9512017. View Article : Google Scholar : PubMed/NCBI
|
42
|
Concetti J and Wilson CL: NFKB1 and
cancer: Friend or foe? Cells. 7:E1332018. View Article : Google Scholar : PubMed/NCBI
|
43
|
Philip S, Bulbule A and Kundu GC: Matrix
metalloproteinase-2: Mechanism and regulation of NF-κB-mediated
activation and its role in cell motility and ECM-invasion.
Glycoconj J. 21:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
44
|
Bharti AC and Aggarwal BB: Nuclear
factor-kappa B and cancer: Its role in prevention and therapy.
Biochem Pharmacol. 64:883–888. 2002. View Article : Google Scholar : PubMed/NCBI
|
45
|
Wang Y, Shen Y, Wang S, Shen Q and Zhou X:
The role of STAT3 in leading the crosstalk between human cancers
and the immune system. Cancer Lett. 415:117–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
46
|
Caetano MS, Hassane M, Van HT, Bugarin E,
Cumpian AM, McDowell CL, Cavazos CG, Zhang H, Deng S, Diao L, et
al: Sex specific function of epithelial STAT3 signaling in
pathogenesis of K-ras mutant lung cancer. Nat Commun. 9:45892018.
View Article : Google Scholar : PubMed/NCBI
|
47
|
Wang J, Lee J, Liem D and Ping P: HSPA5
gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum.
Gene. 618:14–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
48
|
Arap MA, Lahdenranta J, Mintz PJ, Hajitou
A, Sarkis AS, Arap W and Pasqualini R: Cell surface expression of
the stress response chaperone GRP78 enables tumor targeting by
circulating ligands. Cancer Cell. 6:275–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
49
|
Shuda M, Kondoh N, Imazeki N, Tanaka K,
Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, et al:
Activation of the ATF6, XBP1 and grp78 genes in human
hepatocellular carcinoma: A possible involvement of the ER stress
pathway in hepatocarcinogenesis. J Hepatol. 38:605–614. 2003.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Um E, Oh JM, Granick S and Cho YK: Cell
migration in microengineered tumor environments. Lab Chip.
17:4171–4185. 2017. View Article : Google Scholar : PubMed/NCBI
|
51
|
Condeelis J and Pollard JW: Macrophages:
Obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
52
|
Yang Y, Zheng H, Zhan Y and Fan S: An
emerging tumor invasion mechanism about the collective cell
migration. Am J Transl Res. 11:5301–5312. 2019.PubMed/NCBI
|
53
|
Denisenko TV, Gorbunova AS and Zhivotovsky
B: Mitochondrial involvement in migration, invasion and metastasis.
Front Cell Dev Biol. 7:3552019. View Article : Google Scholar : PubMed/NCBI
|
54
|
Li X, Miao Y, Pal DS and Devreotes PN:
Excitable networks controlling cell migration during development
and disease. Semin Cell Dev Biol. Dec 10–2019.(Epub ahead of
print). doi: 10.1016/j.semcdb.2019.11.001.
|
55
|
Mishra AK, Campanale JP, Mondo JA and
Montell DJ: Cell interactions in collective cell migration.
Development. 146:dev1720562019. View Article : Google Scholar : PubMed/NCBI
|
56
|
Greenlee JD and King MR: Engineered
fluidic systems to understand lymphatic cancer metastasis.
Biomicrofluidics. 14:0115022020. View Article : Google Scholar : PubMed/NCBI
|
57
|
Misra UK, Payne S and Pizzo SV: The
monomeric receptor binding domain of tetrameric; α2-macroglobulin
binds to cell surface GRP78 triggering equivalent; activation of
signaling cascades. Biochemistry. 52:4014–4025. 2013. View Article : Google Scholar : PubMed/NCBI
|
58
|
Khosla R, Hemati H, Rastogi A, Ramakrishna
G, Sarin SK and Trehanpati N: MiR-26b-5p helps in EpCAM+cancer stem
cells maintenance via HSC71/HSPA8 and augments malignant features
in HCC. Liver Int. 39:1692–1703. 2019. View Article : Google Scholar : PubMed/NCBI
|
59
|
Xiong Y, Wu S, Yu H, Wu J, Wang Y, Li H,
Huang H and Zhang H: MiR-190 promotes HCC proliferation and
metastasis by targeting PHLPP1. Exp Cell Res. 371:185–195. 2018.
View Article : Google Scholar : PubMed/NCBI
|
60
|
Goh WW, Lee YH, Ramdzan ZM, Chung MC, Wong
L and Sergot MJ: A network-based maximum link approach towards MS
identifies potentially important roles for undetected ARRB1/2 and
ACTB in liver cancer progression. Int J Bioinform Res Appl.
8:155–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
61
|
Song W, Gu Y, Lu S, Wu H, Cheng Z, Hu J,
Qian Y, Zheng Y and Fan H: LncRNA TRERNA1 facilitates
hepatocellular carcinoma metastasis by dimethylating H3K9 in the
CDH1 promoter region via the recruitment of the EHMT2/SNAI1
complex. Cell Prolif. 52:e126212019. View Article : Google Scholar : PubMed/NCBI
|
62
|
Wilson CL, Jurk D, Fullard N, Banks P,
Page A, Luli S, Elsharkawy AM, Gieling RG, Chakraborty JB, Fox C,
et al: NFκB1 is a suppressor of neutrophil-driven hepatocellular
carcinoma. Nat Commun. 6:68182015. View Article : Google Scholar : PubMed/NCBI
|
63
|
Black DL: Mechanisms of alternative
pre-messenger RNA splicing. Annu Rev Biochem. 72:291–336. 2003.
View Article : Google Scholar : PubMed/NCBI
|
64
|
King N, Hittinger CT and Carroll SB:
Evolution of key cell signaling and adhesion protein families
predates animal origins. Science. 301:361–363. 2003. View Article : Google Scholar : PubMed/NCBI
|
65
|
Mukhopadhyay D and Riezman H:
Proteasome-independent functions of ubiquitin in endocytosis and
signaling. Science. 315:201–205. 2007. View Article : Google Scholar : PubMed/NCBI
|